Asthma Clinical Trial
Official title:
Evaluation of the Effectiveness of a Technology-based Program Delivered by Peer-led and Adult Educators to Adolescents Diagnosed With Asthma
The research was planned in a randomized controlled trial to evaluate the effect of technology-based education provided by peers and adults to children diagnosed with asthma in the 12-18 age group. The study will be conducted in two phases. The initial phase will assess the efficacy of the training provided to peer mentors. The subsequent phase will examine the impact of peer-led and adult-delivered technology-based education on quality of life, asthma control, asthma knowledge, and self-efficacy in adolescents diagnosed with asthma. The required institutional permission and ethics committee approval was received. The study group of the study will consist of 45 adolescents (intervention group 1 [n=15], intervention group 2 [n=15], and control group [n=15]). Data will be collected by using the descriptive features form, the Adolescent Asthma Self-Efficiacy Questionaire, the Asthma Quality of Life Scale for Children, the Asthma Control Test, the Asthma Knowledge Test.The data will be analyzed using the SPSS 27 program.
Status | Not yet recruiting |
Enrollment | 45 |
Est. completion date | January 1, 2025 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 18 Years |
Eligibility | Inclusion Criteria: - The study population is comprised of individuals between the ages of 12 and 18 who have been diagnosed with asthma at least three months prior and who do not have any other medical diagnoses of chronic disease. Additionally, they must own and be able to use a smartphone, reliable home internet access, and a computer. Furthermore, they must be proficient in Turkish and not be in the active attack period. Finally, they must not have experienced a stressful event that could affect their quality of life in the last three months, such as an acute illness, the birth of a new sibling, or the death of a family member. Exclusion Criteria: - Those who are unwilling or unable to continue the research Those who fail to participate in the internet-based application on two or more occasions |
Country | Name | City | State |
---|---|---|---|
Turkey | Emine Gunes San | Ankara |
Lead Sponsor | Collaborator |
---|---|
Bartin University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adolescent Asthma Self-Efficacy Questionnaire | The scale is applied to adolescents aged 12-18 with a diagnosis of asthma. Scale items are scored from 0 to 100. The responses to the scale items are added and then divided by 27 to obtain the total average score (0-100). Subscale items are added in the same way and divided by the number of items in each subscale. A higher score indicates higher self-efficacy. | Change from Baseline level to 3 months (change is being assessed) | |
Primary | Asthma Quality of Life Scale for Children | The instrument was developed to assess the physical, mental and social disorders of children diagnosed with asthma in the 7-17 age group. The scores range from 23 to 161. The items on the scale are evaluated using a 7-point Likert scale. A high score indicates a high quality of life, while a low score indicates a low quality of life. | Change from Baseline level to 3 months (change is being assessed) | |
Primary | Asthma Control Test | The Asthma Control Test (ACT) is a five-item instrument designed to assess asthma control. The ACT scores range from 5 to 25, with a score of 5 indicating poor asthma control and a score of 25 indicating complete control of asthma. A score below 19 is generally used to indicate uncontrolled asthma. | Change from Baseline level to 3 months (change is being assessed) | |
Primary | Asthma knowledge test | This form will be created by researchers in accordance with the existing literature. It will be used to evaluate information about asthma symptoms, triggers and treatment. The form will be created in a 3-point Likert type as "True", "False" and "I don't know". In the form, each correct answer will receive "1 point", while incorrect answers and those marked "I don't know" will receive "0 points". A high total score obtained from this form will indicate a high level of knowledge about asthma. | Change from Baseline level to 3 months (change is being assessed) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|